Compare Kinder Morgan Inc (KMI) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Medtronic PLC — how do they compare? Kinder Morgan Inc trades at $32.46 (market cap $72.48B), while Medtronic PLC trades at $82.63 (market cap $106.61B). The key difference: Medtronic PLC is the larger of the two by market cap, and Kinder Morgan Inc pays the higher dividend (3.61%). Which is the better fit depends on your goals.
| KMI | MDT | |
|---|---|---|
Market Cap | $72.48B | $106.61B |
Sector | Energy | Health |
52-Week High | $34.31 | $105.35 |
52-Week Low | $25.84 | $73.75 |
Enterprise Value | $104.36B | $125.36B |
Dividend Yield | 3.61% | 3.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kinder Morgan (KMI) trades at $32.38, up 0.25% for the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q1 2026 earnings, beating estimates with EPS of $0.48 versus $0.3959 expected, and revenue growth of 13.8% year-over-year. Analyst sentiment is mixed with 47% buy ratings, while the stock offers a dividend yield supported by stable cash flows from fee-based contracts.
KMI's outlook is supported by a $10.1 billion project backlog focused on natural gas infrastructure, rising LNG exports, and power demand. Risks include exposure to energy commodity volatility and high debt levels. The stock presents a value opportunity for income investors seeking stable dividends, but requires monitoring of execution on growth projects and energy market conditions.
Medtronic (MDT) trades at $82.35, down 1.02% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.39. Revenue grew to $33.54B in 2025, with a net income margin of 13.2%. Recent news highlights the acquisition of SPR and the launch of AI-powered surgical technology, signaling innovation-driven growth.
The outlook for MDT is positive, supported by analyst consensus with a $97.50 price target and 58% buy ratings. Key opportunities include robust cash flow and dividend stability, while risks involve rising debt levels and competitive pressures in medtech. The stock presents a value proposition with a P/E of 22.33, trading below the consensus target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
